How can you adjust neoadjuvant or adjuvant platinum based chemotherapy for stage Stage II-III non-small cell lung cancer in patients with significant renal insufficiency?   

This is a great question as to one of our key responsibilities as practicing oncologists. Properly tailoring treatment - in this example chemotherapy to our patient’s needs – recognizing particular co-morbidities of concern, his/her willingness to tolerate side effects, and striking the ...

I fully agree with Dr. @Balazs Halmos. Here is the tool you need: Creatinine Clearance (Cockcroft-Gault Equation) - MDCalc.